在西班牙类风湿关节炎患者中使用患者报告的结果测量方法和实施障碍:德尔菲研究。

IF 4 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL
Esteban Rubio, Mª José Moreno, Adela Gallego, Isabel Castrejón, Amelia Cobo, Sebastián Moyano, Marta Comellas
{"title":"在西班牙类风湿关节炎患者中使用患者报告的结果测量方法和实施障碍:德尔菲研究。","authors":"Esteban Rubio, Mª José Moreno, Adela Gallego, Isabel Castrejón, Amelia Cobo, Sebastián Moyano, Marta Comellas","doi":"10.1007/s12325-025-03300-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to investigate the pattern of use and barriers for implementation of patient-reported outcomes measures (PROMs) in patients with rheumatoid arthritis (RA) in Spain.</p><p><strong>Methods: </strong>Two-round Delphi study targeted at rheumatologists attending a PROMs training program and guided by a Scientific Committee composed of four expert rheumatologists was conducted. The survey assessed the current use, appropriateness, and feasibility of 7 PROMs proposed by the International Consortium for Health Outcomes Measurements (ICHOM). Barriers to implement PROMs in routine care were also explored. A 7-point Likert scale was used ranging from 1 (strongly disagree) to 7 (strongly agree). Consensus was established when > 75% reached agreement (rated 6-7 = agreement, or 1-2 = disagreement).</p><p><strong>Results: </strong>A total of 39 rheumatologists of 120 (32%) participated {61.5% women; mean age 50.3 [standard deviation (SD) 11.0] years; mean 18.1 (9.6) years of experience; 23.1% running a RA clinic}. Although 82.1% of rheumatologists agreed on involving patients in shared decision-making (SDM), only 56.4% adopted SDM strategies in treatment decisions. A higher percentage (79.4%) agreed on the importance of incorporating PROMs, but only 28.2% recognized to use them in routine care, being the most frequently used pain on a visual analogue scale (VAS) (89.8%), the Health Assessment Questionnaire (HAQ) (71.7%), and a VAS-fatigue (66.7%). The remaining proposed PROMs by ICHOM did not reach a consensus on either appropriateness or feasibility. The main barriers found included lack of time in consultation (84.6%) and the unavailability of PROMs platforms incorporated in the electronic medical records (87.9%).</p><p><strong>Conclusion: </strong>Spanish rheumatologists consider PROMs useful to guide SDM in routine care being the most frequently used pain, fatigue, and physical function. However, other domains proposed by ICHOM as health-related quality of life (HRQoL) or work/school productivity are not commonly used. Promoting the use of PROMs strategies, including optimizing consultation time and incorporating PROMs into electronic medical records, is necessary.</p>","PeriodicalId":7482,"journal":{"name":"Advances in Therapy","volume":" ","pages":""},"PeriodicalIF":4.0000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Use of Patient-Reported Outcome Measures in Patients with Rheumatoid Arthritis in Spain and Barriers to Implementation: A Delphi Study.\",\"authors\":\"Esteban Rubio, Mª José Moreno, Adela Gallego, Isabel Castrejón, Amelia Cobo, Sebastián Moyano, Marta Comellas\",\"doi\":\"10.1007/s12325-025-03300-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>This study aimed to investigate the pattern of use and barriers for implementation of patient-reported outcomes measures (PROMs) in patients with rheumatoid arthritis (RA) in Spain.</p><p><strong>Methods: </strong>Two-round Delphi study targeted at rheumatologists attending a PROMs training program and guided by a Scientific Committee composed of four expert rheumatologists was conducted. The survey assessed the current use, appropriateness, and feasibility of 7 PROMs proposed by the International Consortium for Health Outcomes Measurements (ICHOM). Barriers to implement PROMs in routine care were also explored. A 7-point Likert scale was used ranging from 1 (strongly disagree) to 7 (strongly agree). Consensus was established when > 75% reached agreement (rated 6-7 = agreement, or 1-2 = disagreement).</p><p><strong>Results: </strong>A total of 39 rheumatologists of 120 (32%) participated {61.5% women; mean age 50.3 [standard deviation (SD) 11.0] years; mean 18.1 (9.6) years of experience; 23.1% running a RA clinic}. Although 82.1% of rheumatologists agreed on involving patients in shared decision-making (SDM), only 56.4% adopted SDM strategies in treatment decisions. A higher percentage (79.4%) agreed on the importance of incorporating PROMs, but only 28.2% recognized to use them in routine care, being the most frequently used pain on a visual analogue scale (VAS) (89.8%), the Health Assessment Questionnaire (HAQ) (71.7%), and a VAS-fatigue (66.7%). The remaining proposed PROMs by ICHOM did not reach a consensus on either appropriateness or feasibility. The main barriers found included lack of time in consultation (84.6%) and the unavailability of PROMs platforms incorporated in the electronic medical records (87.9%).</p><p><strong>Conclusion: </strong>Spanish rheumatologists consider PROMs useful to guide SDM in routine care being the most frequently used pain, fatigue, and physical function. However, other domains proposed by ICHOM as health-related quality of life (HRQoL) or work/school productivity are not commonly used. Promoting the use of PROMs strategies, including optimizing consultation time and incorporating PROMs into electronic medical records, is necessary.</p>\",\"PeriodicalId\":7482,\"journal\":{\"name\":\"Advances in Therapy\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2025-07-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in Therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s12325-025-03300-w\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12325-025-03300-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

简介:本研究旨在调查西班牙类风湿关节炎(RA)患者报告结果测量(PROMs)的使用模式和实施障碍。方法:在由4名风湿病专家组成的科学委员会的指导下,针对参加PROMs培训项目的风湿病学家进行两轮德尔菲研究。该调查评估了国际健康结果测量联合会(ICHOM)提出的7种PROMs的当前使用、适当性和可行性。探讨了在常规护理中实施PROMs的障碍。采用李克特7分量表,从1(非常不同意)到7(非常同意)。当b> 75%达成一致(6-7 =同意,1-2 =不同意)时,达成共识。结果:共有120名(32%)的39名风湿病学家参与其中;平均年龄50.3[标准差(SD) 11.0]岁;平均工作经验18.1年(9.6年);23.1%的人开了类风湿性关节炎诊所。尽管82.1%的风湿病学家同意让患者参与共同决策(SDM),但只有56.4%的人在治疗决策中采用SDM策略。较高百分比(79.4%)同意纳入PROMs的重要性,但只有28.2%的人承认在日常护理中使用它们,是视觉模拟量表(VAS)(89.8%),健康评估问卷(HAQ)(71.7%)和VAS-疲劳(66.7%)中最常用的疼痛。科协委会提出的其余建议在适当性或可行性方面均未达成协商一致意见。发现的主要障碍包括咨询时间不足(84.6%)和电子病历中没有纳入prom平台(87.9%)。结论:西班牙风湿病学家认为PROMs有助于指导SDM在常规护理中最常用的疼痛、疲劳和身体功能。然而,ICHOM提出的与健康相关的生活质量(HRQoL)或工作/学校生产力等其他领域并不常用。有必要促进promms战略的使用,包括优化会诊时间和将promms纳入电子病历。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Use of Patient-Reported Outcome Measures in Patients with Rheumatoid Arthritis in Spain and Barriers to Implementation: A Delphi Study.

Introduction: This study aimed to investigate the pattern of use and barriers for implementation of patient-reported outcomes measures (PROMs) in patients with rheumatoid arthritis (RA) in Spain.

Methods: Two-round Delphi study targeted at rheumatologists attending a PROMs training program and guided by a Scientific Committee composed of four expert rheumatologists was conducted. The survey assessed the current use, appropriateness, and feasibility of 7 PROMs proposed by the International Consortium for Health Outcomes Measurements (ICHOM). Barriers to implement PROMs in routine care were also explored. A 7-point Likert scale was used ranging from 1 (strongly disagree) to 7 (strongly agree). Consensus was established when > 75% reached agreement (rated 6-7 = agreement, or 1-2 = disagreement).

Results: A total of 39 rheumatologists of 120 (32%) participated {61.5% women; mean age 50.3 [standard deviation (SD) 11.0] years; mean 18.1 (9.6) years of experience; 23.1% running a RA clinic}. Although 82.1% of rheumatologists agreed on involving patients in shared decision-making (SDM), only 56.4% adopted SDM strategies in treatment decisions. A higher percentage (79.4%) agreed on the importance of incorporating PROMs, but only 28.2% recognized to use them in routine care, being the most frequently used pain on a visual analogue scale (VAS) (89.8%), the Health Assessment Questionnaire (HAQ) (71.7%), and a VAS-fatigue (66.7%). The remaining proposed PROMs by ICHOM did not reach a consensus on either appropriateness or feasibility. The main barriers found included lack of time in consultation (84.6%) and the unavailability of PROMs platforms incorporated in the electronic medical records (87.9%).

Conclusion: Spanish rheumatologists consider PROMs useful to guide SDM in routine care being the most frequently used pain, fatigue, and physical function. However, other domains proposed by ICHOM as health-related quality of life (HRQoL) or work/school productivity are not commonly used. Promoting the use of PROMs strategies, including optimizing consultation time and incorporating PROMs into electronic medical records, is necessary.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Advances in Therapy
Advances in Therapy 医学-药学
CiteScore
7.20
自引率
2.60%
发文量
353
审稿时长
6-12 weeks
期刊介绍: Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged. The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信